Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict Ruby Khatun Khatun19 Feb 2018 4:15 AM GMTA federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
Merck's consumer health sale at risk as Nestle bows out, says report Ruby Khatun Khatun6 Feb 2018 4:15 AM GMTThe sale of Merck KGaA's consumer health unit has been thrown off track after Nestle has pulled out, leaving the race to buy the maker of Seven Seas...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 4:45 AM GMTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
Roche drug cocktail doubles chance of holding lung cancer at bay Ruby Khatun Khatun9 Dec 2017 4:15 AM GMTZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease ...
Nestle, Stada prepare rival bids for Merck consumer health: sources Ruby Khatun Khatun6 Dec 2017 3:30 AM GMTLONDON/FRANKFURT: Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's...
UK announces pharma investment, aims to boost productivity Ruby Khatun Khatun1 Dec 2017 4:15 AM GMTLONDON: Britain has announced a major investment by US drug-maker Merck, as the UK government unveils plans to boost productivity after Brexit.The...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 4:00 AM GMTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 4:30 AM GMTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 4:31 AM GMTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 4:00 AM GMTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
Merck cyber attack may cost insurers 275 million dollars: Verisks PCS Ruby Khatun Khatun23 Oct 2017 4:27 AM GMTNEW YORK: Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a...
Police raid French HQ of pharma giant Merck Ruby Khatun Khatun5 Oct 2017 4:19 AM GMTParis: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical...
